Lonza will establish Centers of Excellence for Cell and Gene Therapy to support and accelerate the growth of this priority area for the company. This decision advances Lonza’s strategy of being one of the world’s leading, integrated, value-added solutions providers along the healthcare continuum. To further improve its support to customers, Lonza’s Cell- and Gene-Therapy Centers of Excellence will include Lonza sites that are already serving customers and their patients with these innovative technologies. The Lonza sites in Pearland, TX…
Author Archives: BPI Contributor
Gilson Introduces Gilson Connect: A Cloud-Connected Platform Powering New Tools to Help Researchers Achieve Verifiable Science
Gilson launches Gilson Connect, a cloud-connected platform that powers a product line of Bluetooth®-enabled, smart liquid handling devices designed to help scientists achieve verifiable science. The first smart products include the TRACKMAN® Connected and PIPETMAN® M Connected. These new lab instruments give scientists the ability to record and track pipette performance data in real-time and transmit them to sciNote, a free, open-source electronic lab notebook (ELN). “Gilson is bringing the potential of the Internet of Things to the lab, creating…
JSR’s Life Sciences Division Appoints New CEO for MBL International
JSR Life Sciences, the life sciences-focused business unit of JSR Corporation, announced today that it has appointed Dr. Nalini Murdter as the President and Chief Executive Officer of MBL International (MBLI) effective immediately. This leadership transition at MBLI comes on the heels of JSR’s recent acquisition of contract research organization, Crown Biosciences in which JSR sees great potential for synergy. Whereas MBLI specializes in detecting and analyzing disease biomarkers and pathways, Crown’s expertise lies in supporting drug discovery, development and…
KBI Biopharma Acquires Elion Labs to Further Expand Industry-Leading Biophysical and Analytical Characterization Capabilities
KBI Biopharma, Inc. (KBI) has completed the acquisition of the assets of Elion Labs (Elion), a leading contract services organization in Louisville, CO founded to serve the analytical development and product characterization needs of the biopharmaceutical industry. Elion’s services include analytical method development, qualification and validation, characterization of biologics, and comprehensive data analysis including visualization and interpretation of complex data sets. This acquisition further strengthens KBI’s analytical and biophysical characterization capabilities following the company’s acquisition of Alliance Protein Laboratories in…
Wuxi Griffin is a New Aseptic Filling Contract Manufacturer Based in China with Western Management and Western Regulatory Compliance
Wuxi Griffin has recently completed construction of their 2,550 m2 filling facility in Wuxi, China. It is a Swedish and a Chinese company that have joined forces in this new project. The new contract manufacturer Wuxi Griffin will focus on providing aseptic filling services globally to western GMP standards. Products to be manufactured in the new facility include MAbs, vaccine, recombinant proteins as well as biosimilars and small molecule drugs (traditional). RABS and Isolator production technology is in place for…
CEVEC Introduces New Helper-Free AAV Packaging Cell Line for Scalable Stable Gene Threapy Vector Production
Pharmaceuticals GmbH (CEVEC) announced the introduction of a new solution for scalable stable viral vector production for gene therapy applications. Dr. Nicole Faust, CEO & CSO of CEVEC presented data from the Company’s successful proof-of-concept studies with these newly introduced cell lines on January 24, 2018 at Phacilitate. Based on its proprietary CAP-GT manufacturing platform of suspension cell lines, CEVEC has successfully developed a novel AAV (adeno-associated virus) stable production system that allows for easy scale up in all existing…
Bio-Rad Launches NGC Fraction Collector for NGC Chromatography Systems
Bio-Rad Laboratories, Inc. has launched the new NGC Fraction Collector. When used with the NGC Chromatography System, the NGC Fraction Collector provides the flexibility and collection capacity needed for any application, from discovery to scale-up. The NGC Fraction Collector allows researchers to choose how to collect and when to access their fractions. The system can be triggered to collect based on slope, percent of buffer from pump B, pH, and detector signals. Front-to-back dispensing provides easy access to fractions before…
PharmaFluidics Raises 7.3 Million Euro to Expand Commercialization of Novel Microchip Device for Biomarker, Diagnostics and Drug Development Applications
PharmaFluidics NV announced in January that it has raised 7.3 million euro. The company will focus on intensifying international growth, supported by initial, promising sales. The financing came from investors including holding company FPIM-SFPI, and family offices Heran (Annie Vereecken) and RMM (Rudi Mariën). The existing investors PMV, Qbic, Theodorus, Innovation Fund and Volksvermogen reaffirm their confidence in the company and also participated in this financing round. The VUB spin-off has a unique technology, the µPACᵀᴹ column series, which offers…
AGC Bioscience, Biomeva, and CMC Biologics to Provide Services Under the Brand AGC Biologics
AGC Biologics, a convergence of Asahi Glass Company (AGC) Bioscience, Biomeva GmbH, and CMC Biologics, announced today that effective January 8, 2018, the company will be integrated and newly branded as AGC Biologics. AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, will offer the highest level of CDMO services to its clients from their state-of-the-art facilities in Seattle, WA and Berkeley, CA in the US; Copenhagen, Denmark; Heidelberg, Germany; Chiba, Japan; and Yokohama, Japan. The…
Abzena Selects Sartorius Stedim Biotech to Equip Development and Manufacturing Sites in the United States
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S. Abzena has selected Sartorius Stedim to equip its integrated CDMO facilities in Bristol, PA (development and GMP manufacture of antibody drug conjugates) and San Diego, CA (development and GMP manufacture of monoclonal antibodies and other recombinant proteins). Sartorius Stedim will provide both facilities with end-to-end process solutions in…